Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 18Terminated 8Unknown 7Recruiting 6Not yet recruiting 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 27Lung Neoplasms 5Small Cell Lung Carcinoma 2Pancreatic Neoplasms 2Neoplasm Metastasis 2NSCLC 2Brain Neoplasms 2Adenocarcinoma of Lung 2Solid Tumor Cancer 1Non-squamous Non-small Cell Lung Cancer 1Non-small Cell Lung Cancer Metastatic 1Non Squamous Non-small Cell Lung Cancer 1Neoplasms 1Mesothelioma, Malignant 1Meningeal Carcinomatosis 1Melanoma 1Lymphatic Metastasis 1Lung Non-Squamous Non-Small Cell Carcinoma 1Lung Diseases, Interstitial 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Disease Progression 1Diabetes Mellitus, Insulin-Dependent, 12 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma 1Advanced Solid Tumor 1

Interventions

aflutinib 2Pemetrexed 2lorlatinib 1anlotinib 1Platinum 1Orlistat 1Mastectomy, Segmental 1Diagnostic Imaging 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Adenocarcinoma of Lung × Pemetrexed × Clear all
NCT07624487 2026-06-03

A Phase II Study of Aumolertinib Combined With Phased Chemotherapy for EGFR L858R Lung Adenocarcinoma

Taipei Medical University Hospital

Phase 2 Not yet recruiting
50 enrolled
Thoracic

Adenocarcinoma of Lung

NCT07416058 2026-02-17

PHOENIX

Guangdong Association of Clinical Trials

Phase 2 Not yet recruiting
61 enrolled
Thoracic

Diabetes Mellitus, Insulin-Dependent, 12, Adenocarcinoma of Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡